ACE2 and COVID-19: Moreover, NM potently inhibits the activity of transmembrane serine protease 2 (TMPRSS2), thereby impeding the binding of SARS-CoV-2 to angiotensin-converting enzyme 2 (ACE2), a pivotal mechanism underlying its therapeutic efficacy against COVID-19 (Hoffmann et al., 2020).